XML 63 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Goodwill and Other Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in carrying amount of goodwill
The changes in the carrying amount of goodwill for the years ended December 31, 2014 and 2013 are as follows:
 
(In millions)
Generics Segment
 
Specialty Segment
 
Total
Balance at December 31, 2012:
 
 
 
 
 
Goodwill
$
3,194.1

 
$
706.5

 
$
3,900.6

Accumulated impairment losses
—

 
(385.0
)
 
(385.0
)
 
3,194.1

 
321.5

 
3,515.6

Acquisitions
956.4

 
—

 
956.4

Transfers (1)
(27.6
)
 
27.6

 
—

Foreign currency translation
(131.5
)
 
—

 
(131.5
)
 
3,991.4

 
349.1

 
4,340.5

Balance at December 31, 2013:
 
 
 
 
 
Goodwill
3,991.4

 
734.1

 
4,725.5

Accumulated impairment losses
—

 
(385.0
)
 
(385.0
)
 
3,991.4

 
349.1

 
4,340.5

Acquisitions
13.3

 
—

 
13.3

Divestment
(10.5
)
 
—

 
(10.5
)
Foreign currency translation
(294.0
)
 
—

 
(294.0
)
 
3,700.2

 
349.1

 
4,049.3

Balance at December 31, 2014:
 
 
 
 
 
Goodwill
3,700.2

 
734.1

 
4,434.3

Accumulated impairment losses
—

 
(385.0
)
 
(385.0
)
 
$
3,700.2

 
$
349.1

 
$
4,049.3

____________
(1) 
As a result of the January 1, 2013 reorganization of certain components between the Generics and Specialty segments, the Company was required to reassign a portion of the carrying amount of goodwill to the Specialty segment.
Components of intangible assets
Intangible assets consist of the following components at December 31, 2014 and 2013:
 
(In millions)
Weighted
Average Life
(Years)
 
Original
Cost
 
Accumulated
Amortization
 
Net Book
Value
December 31, 2014
 
 
 
 
 
 
 
Amortized intangible assets:
 
 
 
 
 
 
 
Patents and technologies
20
 
$
116.6

 
$
99.2

 
$
17.4

Product rights and licenses
10
 
3,617.0

 
2,127.8

 
1,489.2

Other (1)
8
 
162.2

 
70.6

 
91.6

 
 
 
3,895.8

 
2,297.6

 
1,598.2

In-process research and development
 
 
748.9

 
—

 
748.9

 
 
 
$
4,644.7

 
$
2,297.6

 
$
2,347.1

December 31, 2013
 
 
 
 
 
 
 
Amortized intangible assets:
 
 
 
 
 
 
 
Patents and technologies
20
 
$
116.6

 
$
93.8

 
$
22.8

Product rights and licenses
10
 
3,559.5

 
2,018.1

 
1,541.4

Other (1)
8
 
174.0

 
59.4

 
114.6

 
 
 
3,850.1

 
2,171.3

 
1,678.8

In-process research and development
 
 
839.1

 
—

 
839.1

 
 
 
$
4,689.2

 
$
2,171.3

 
$
2,517.9

____________
(1) 
Other intangibles consist principally of customer lists and contracts.
Product rights and licenses by therapeutic category
Product rights and licenses are primarily comprised of the products marketed at the time of acquisition. These product rights and licenses relate to numerous individual products, the net book value of which, by therapeutic category, is as follows:
 
(In millions)
December 31, 2014
 
December 31, 2013
Allergy
$
82.5

 
$
95.9

Anti-infectives
152.8

 
194.2

Antineoplastic
123.7

 
147.4

Cardiovascular
175.0

 
235.8

Central Nervous System
199.5

 
211.2

Dermatological
65.9

 
79.6

Endocrine and Metabolic
54.8

 
72.4

Gastrointestinal
67.6

 
95.2

Hematological Agents
294.5

 
14.9

Respiratory System
78.3

 
147.4

Other (1) 
194.6

 
247.4

 
$
1,489.2

 
$
1,541.4

____________
(1) 
Other consists of numerous therapeutic classes, none of which individually exceeds 5% of total product rights and licenses.